- Home
- Publications
- Publication Search
- Publication Details
Title
Theory and strategy for Pneumococcal vaccines in the elderly
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 12, Issue 2, Pages 336-343
Publisher
Informa UK Limited
Online
2015-09-25
DOI
10.1080/21645515.2015.1075678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced
- (2015) Qiuzhi Chang et al. BMC INFECTIOUS DISEASES
- Aspiration pneumonia: A review of modern trends
- (2015) David M. DiBardino et al. JOURNAL OF CRITICAL CARE
- Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries
- (2015) Meredith L. McMorrow et al. JOURNAL OF INFECTIOUS DISEASES
- Towards a comprehensive public health response to population ageing
- (2015) John R Beard et al. LANCET
- Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
- (2015) Pauline A Waight et al. LANCET INFECTIOUS DISEASES
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Developing vaccines for an aging population
- (2015) Steven Black et al. Science Translational Medicine
- Burden of invasive pneumococcal disease (IPD) in Sri-Lanka: Deriving a reasonable measure for vaccine introduction decision making
- (2015) S. Kularatna et al. VACCINE
- Comparison of the immunogenicity and safety of polysaccharide and protein-conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan: An open-labeled randomized study
- (2015) Ho Namkoong et al. VACCINE
- Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe
- (2015) Julia Blau et al. VACCINE
- Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
- (2014) Jaime E Ordóñez et al. BMC INFECTIOUS DISEASES
- Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study
- (2014) O. Ochoa-Gondar et al. CLINICAL INFECTIOUS DISEASES
- The role of vaccination in preventing pneumococcal disease in adults
- (2014) S. Aliberti et al. CLINICAL MICROBIOLOGY AND INFECTION
- A systems biology approach to the effect of aging, immunosenescence and vaccine response
- (2014) Gregory A Poland et al. CURRENT OPINION IN IMMUNOLOGY
- Recent trends in epidemiology of invasive pneumococcal disease in Poland
- (2014) A. Skoczyńska et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic
- (2014) Anita S Iyer et al. Expert Review of Vaccines
- Economic impact of 13-valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions
- (2014) Janne A. Martikainen et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
- (2014) Anne von Gottberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pneumococcal Carriage in Sub-Saharan Africa—A Systematic Review
- (2014) Effua Usuf et al. PLoS One
- Non-Invasive Pneumococcal Pneumonia in Portugal—Serotype Distribution and Antimicrobial Resistance
- (2014) Andreia N. Horácio et al. PLoS One
- Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults
- (2014) John D. Grabenstein et al. VACCINE
- PCV7-induced changes in pneumococcal carriage and invasive disease burden in Alaskan children
- (2014) James W. Keck et al. VACCINE
- Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age
- (2014) Richard N. Greenberg et al. VACCINE
- Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK
- (2014) Yiling Jiang et al. Expert Review of Pharmacoeconomics & Outcomes Research
- High incidence of septic shock caused by Streptococcus pneumoniae serotype 3 - a retrospective epidemiological study
- (2013) Jonas Ahl et al. BMC INFECTIOUS DISEASES
- Pneumococcal infection in adults: burden of disease
- (2013) J.J.C. Drijkoningen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hospital-acquired pneumonia and ventilator-associated pneumonia
- (2013) François Barbier et al. CURRENT OPINION IN PULMONARY MEDICINE
- Preventing Pneumococcal Disease in the Elderly
- (2013) Angel Vila-Corcoles et al. DRUGS & AGING
- The history of pneumococcal conjugate vaccine development: dose selection
- (2013) Jan T Poolman et al. Expert Review of Vaccines
- Regulation of AID, the B-cell genome mutator
- (2013) C. Keim et al. GENES & DEVELOPMENT
- Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention
- (2013) Ivan Fan-Ngai Hung et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Community-acquired pneumonia during the first post-pandemic influenza season: A prospective, multicentre cohort study
- (2013) Diego Viasus et al. JOURNAL OF INFECTION
- Understanding immunosenescence to improve responses to vaccines
- (2013) Jörg J Goronzy et al. NATURE IMMUNOLOGY
- U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
- (2013) Marie R. Griffin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
- (2013) Lisa A. Jackson et al. VACCINE
- Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: A meta-analysis
- (2013) J. Ruiz-Aragón et al. VACCINE
- The role of health economic analyses in vaccine decision making
- (2013) Steven Black VACCINE
- Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions
- (2013) Bo-Hyun Cho et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
- (2013) Lisa A. Jackson et al. VACCINE
- Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
- (2013) Lisa A. Jackson et al. VACCINE
- Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease
- (2013) Nobuharu Ohshima et al. VACCINE
- Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines
- (2013) Pilar Ciruela et al. Human Vaccines & Immunotherapeutics
- Pneumococcal vaccination of older adults
- (2013) David S. Fedson et al. Human Vaccines & Immunotherapeutics
- Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010
- (2012) Walter H.B. Demczuk et al. CANADIAN JOURNAL OF MICROBIOLOGY
- Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease
- (2012) Mark T. Dransfield et al. CLINICAL INFECTIOUS DISEASES
- Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine
- (2012) Kenneth J. Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients
- (2012) Selma Tobudic et al. PLoS One
- Signaling pathways in aged T cells – A reflection of T cell differentiation, cell senescence and host environment
- (2012) Jörg J. Goronzy et al. SEMINARS IN IMMUNOLOGY
- Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine
- (2012) Karin E.M. Elberse et al. VACCINE
- Pneumococcal polysaccharide 23-valent vaccine: Long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults
- (2012) John D. Grabenstein et al. VACCINE
- Diagnostic Tests for Agents of Community-Acquired Pneumonia
- (2011) John G. Bartlett CLINICAL INFECTIOUS DISEASES
- Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
- (2011) Daniel M. Musher et al. Human vaccines & immunotherapeutics
- Serotype replacement in disease after pneumococcal vaccination
- (2011) Daniel M Weinberger et al. LANCET
- Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness☆☆☆
- (2011) Laura L. Hammitt et al. VACCINE
- Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis
- (2011) Birgit Simell et al. VACCINE
- Effects of Community-Wide Vaccination with PCV-7 on Pneumococcal Nasopharyngeal Carriage in The Gambia: A Cluster-Randomized Trial
- (2011) Anna Roca et al. PLOS MEDICINE
- Capsules ofStreptococcus pneumoniaeand Other Bacteria: Paradigms for Polysaccharide Biosynthesis and Regulation
- (2010) Janet Yother Annual Review of Microbiology
- Impact of the Pneumococcal Vaccine on Long‐Term Morbidity and Mortality of Adults at High Risk for Pneumonia
- (2010) Jennie Johnstone et al. CLINICAL INFECTIOUS DISEASES
- Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis
- (2010) Daniel M. Weinberger et al. CLINICAL INFECTIOUS DISEASES
- A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
- (2010) Neil French et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan
- (2010) Kenji Kawakami et al. VACCINE
- Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease
- (2009) Mark T. Dransfield et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55–70 Years of Age
- (2009) Karen M. Miernyk et al. CLINICAL INFECTIOUS DISEASES
- The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years
- (2009) David Goldblatt et al. CLINICAL INFECTIOUS DISEASES
- Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan
- (2009) N. CHIBA et al. EPIDEMIOLOGY AND INFECTION
- The Streptococcus pneumoniae Capsule Inhibits Complement Activity and Neutrophil Phagocytosis by Multiple Mechanisms
- (2009) C. Hyams et al. INFECTION AND IMMUNITY
- Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention
- (2009) Joseph Lynch et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- B cells and aging: molecules and mechanisms
- (2009) Michael P. Cancro et al. TRENDS IN IMMUNOLOGY
- Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: A systematic review of conclusions and assumptions
- (2009) Isla Ogilvie et al. VACCINE
- Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
- (2008) Lisa A. Jackson et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory
- (2008) Andrés de Roux et al. CLINICAL INFECTIOUS DISEASES
- Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects
- (2008) Richard Aspinall et al. EXPERIMENTAL GERONTOLOGY
- Innate immunity and aging
- (2008) Christian R. Gomez et al. EXPERIMENTAL GERONTOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started